← Open Payments lookup

STEPHEN REALE: Open Payments

NPI 1396846572 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,122 in 47 payments from 15 companies in 2025. Trend: 2023 $462 · 2024 $932 · 2025 $1,122

Food & beverage: $1,122
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$135
Amgen Inc.7$124
Vanda Pharmaceuticals Inc.4$114
Lilly USA, LLC4$114
SANOFI-AVENTIS U.S. LLC4$95
AstraZeneca Pharmaceuticals LP4$91
Phathom Pharmaceuticals, Inc.3$88
Boehringer Ingelheim Pharmaceuticals, Inc.3$79
Merck Sharp & Dohme LLC3$74
ABBVIE INC.4$69

Products named: CAPLYTA, FANAPT, OTEZLA, TZIELD, VOQUEZNA, JARDIANCE, GARDASIL 9, VRAYLAR.

Industry payments across CA — which companies pay providers there.